Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin

Citation:
Syrovets, T., B. Buechele, M. El Gaafary, R. M. Ayala, A. Abderrazak, D. Couchie, D. F. Mahmood, R. Elhage, C. Vindis, M. Laffargue, et al., "Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin", NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, vol. 389, no. SUPPL 1: SPRINGER ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, pp. 34–34, 2016.

Abstract:

n/a

Notes:

n/a

Tourism